Yuying Liu

Feb 15, 2024 | molecular-cancer.biomedcentral.com | Bo Huang |Qiang Ma |Feifei Yang |Xiaojuan Pan |Yuying Zhang |Yuying Liu | +8 more

We collected 152 paired human ccRCC and adjacent nontumor tissues (4 paired tissues for screening phase and 148 paired tissues for validation phase) from the Southwest Hospital of the Army Medical University (Chongqing, China, 2019–2022). Clinical characteristics are listed in Supplementary Table S1-2. The diagnosis of ccRCC was confirmed via histopathological examination. This study was approved by the Ethics Committee of Southwest Hospital of Army Medical University (approval number: KY2020121).

Jul 5, 2023 | frontiersin.org | Yuying Liu |Francesco Pepe |Mohan Rudrappa |Francesco Sollitto

1 IntroductionBladder metastasis of lung adenocarcinoma is extremely rare, and thus, the diagnosis in such a situation requires careful differentiation from primary bladder cancer. Because the symptoms and imaging findings are similar, differential diagnoses of primary bladder tumors from metastatic tumors should be based on accurate pathologic evaluation and, above all, on specific immunohistochemical staining.